DE
MRK icon

Defiance ETFs’s Merck MRK Stock Holding History

Defiance ETFs’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
10,312
+2,031
+25% +$238K 0.02% 231
2026
Q1 		$996K Buy
+8,281
New +$956K 0.01% 217

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Defiance ETFs's MRK Position: Q2 2026 in Review

Defiance ETFs increased its Merck (MRK) stake by 25% in Q2 2026, buying an estimated $238K and bringing the position to 10,312 shares worth $1.29M. The position accounts for 0.02% of the portfolio, ranked #231.

Defiance ETFs first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Defiance ETFs held 10,312 shares of Merck worth $1.29M as of Q2 2026.
  • Defiance ETFs bought 2,031 Merck shares in Q2 2026, an estimated $238K.
  • Merck made up 0.02% of Defiance ETFs's portfolio in Q2 2026, its #231 holding.
  • Defiance ETFs first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.